Clinical
How to identify and manage pre-myopes
In this article:
How can we identify and manage pre-myopes? The pre-myope has a high risk of myopia onset - definitions, clinical communication and the latest research on treatment options are described.
First published: October 18, 2020
Last updated: December 9, 2024.
Imagine this clinical picture: your patient is six years old and refraction is plano. Mum is -2.00D and Dad is -4.00D. Clearly this is not a normal refractive state for a six year old, and her parental history of myopia is concerning - this is a pre-myope. How can we consistently identify pre-myopes, explain the concern to parents, and how can we best manage them?
What is pre-myopia?
The International Myopia Institute - Defining and Classifying Myopia report1 clearly defines the pre-myope:
Pre-myopia – a refractive state of an eye of ≤ +0.75 D and > -0.50 D in children where a combination of baseline refraction, age, and other quantifiable risk factors provide a sufficient likelihood of the future development of myopia to merit preventative interventions.
This definition is made because while reducing progression of myopia is "a central goal of myopia research... preventing the onset of myopia is an even more valuable target." Identifying pre-myopia involves recognising a situation where a child has a non-myopic refraction, but a cluster of risk factors and/or "an observed pattern of eye growth" which indicates a high risk of progression to myopia."
Identifying the pre-myope
There are four key principles for assessing risk of myopia onset:
- Family history – one myopic parent increases risk by three-fold, while two myopic parents doubles this risk again2
- Visual environment – less than 90 minutes a day spent outdoors increases risk, especially if combined with more than 3 hours a day spent on near work activities (outside of school time)3
- Binocular vision – Children with higher accommodative convergence (AC/A) ratios, typically seen with esophoria, have an increased risk of myopia development within one year of over 20 times.4 Accommodative lag may also be a risk factor but there is conjecture.5 Intermittent exotropia has also been associated with onset of myopia.6
- Current refraction (also known as ‘hyperopic reserve’) – the most significant risk factor of this lot for future myopia is if a child exhibits less than 0.75D of manifest hyperopia at age 6-7. This risk is independent of family history and visual environment, and was determined from the multi-ethnic CLEERE study in the USA.7 The hyperopic reserve is likely higher for Asian children (~+1.50D), which may or may not vary with age - read more in our article What is the 'hyperopic reserve' in pre-myopia?
In addition to this, the fastest rate of refractive change in myopic children occurs in the year prior to onset,8 so the child who is less hyperopic than age normal should be closely monitored, especially if concurrent risk factors are evident.
The most significant risk factor for future myopia is if a child is less hyperopic than they should be, independent of all other factors. The 'hyperopic reserve’ is the amount which is protective against myopia development, and may be influenced by ethnicity.
Also watch closely for the child who loses hyperopia quickly between visits, as the fastest refractive shift in myopes occurs in the year just prior to myopia onset.
How quickly should refraction change in emmetropization? The large-scale Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study followed almost 5,000 children aged 6 to 14 for over a decade. Measured by cycloplegic autorefraction, emmetropia was defined as refractive error in the horizontal and vertical meridians between +1.00D and -0.25D. In their paper Normal Eye Growth in Emmetropic Schoolchildren,9 Zadnik et al demonstrated that the horizontal meridian changed from a mean of 0.64D at age 6 to 0.28D at age 14, and the vertical meridian from a mean of 0.58D at age 6 to 0.33D at age 14. Putting this into clinical terms:
If your school aged, presumed emmetropic patient loses 0.50D or more of age-normal hyperopia in a year, you may be looking at a future myope.
Explaining pre-myopia to parents
After you have identified the pre-myope, the next challenge is explaining this to parents. The Myopia Profile Managing Myopia Guidelines Infographic, patient brochure and customizable insert (free to download and available in 20 language translations) help to explain risk using clear categories and a simple green / yellow / red traffic light risk categorization. Put simply, more yellow and red risk factors will escalate the overall risk of myopia development and progression. Perhaps the message on managing pre-myopia is even easier to communicate than for myopia management, when the child already needs vision correction.
The key message to parents which will gain traction is probably the short-term view - a chance to delay or prevent their child's need for full time wear of glasses or contact lenses. A myopic parent especially will find this easy to understand.
Section 1 from the Myopia Profile Managing Myopia Guidelines Clinical Practice Infographic, from the 'Myopia Management in Practice' side which provides a reference guide for eye care professionals on myopia risk factors, prescribing decision trees, follow up schedules and gauging long term myopia management success.
Importance of managing pre-myopia
Managing the pre-myope is arguably more challenging than managing the myope - as the child does not yet require vision correction, this can make optical treatments more challenging for compliance. There is only a small amount of research on interventions for pre-myopia, but it is growing, which is important as the International Myopia Institute states that preventing myopia is an "even more valuable target"1 for science and practice than reducing progression after onset.
Prevention is a powerful but challenging target to accomplish. Each earlier year of onset is associated with approximately -0.75 to -1.00D increased myopia later in life.10 Therefore, focusing attention on the formative stages of myopia and proactively managing pre-myopia could have much greater positive repercussions compared to myopia control after onset.
Delaying myopia by 1 year has a similar long-term effect as two to three years of myopia control with current treatments.10
Pre-myopia interventions
Increased outdoor time
Children who spend less time outdoors are far more likely to develop myopia.11 This is especially the case when two hours or less a day of outdoor time is combined with more than 3 hours of near work outside of schooltime.3
The magic amount of outdoor time appears to be at least two hours per day which can be spread across the week - more precisely, 13+ hours per week as found by meta-analysis.11 On the basis of five studies investigating a dose response, they found that "an increase of 76 min/day, was needed to obtain a 50% reduction in incident myopia, while an increase of 1 hr/day or 7 hr/week will result in a 45% reduction in incident myopia compared with controls."
Research indicates we should aim to increase outdoor time to a total of around two hours per day, average, to have the greatest effect on delaying or preventing myopia onset.
How increased outdoor time confers protection against myopia onset is another mystery. The physiological effects of light exposure, the brightness of outdoor light, the uniformity of the dioptric visual field and spatial frequency of the visual environment have all been suggested as potential mechanisms.12-14 An interesting randomized controlled trial in China15 evaluated the effect of modifying the walls of an indoor classroom to resemble an outdoor scene on myopia development, as opposed to implementing increased outdoor time as most other studies. Preliminary results showed efficacy of the outdoor scene classroom in preserving the hyperopic reserve in students aged 8-10 with ⩽+1.00D hyperopia over 1 year (-0.26D vs -0.40 D, 0.15 mm vs 0.22 mm). It was not effective in altering refractive changes in emmetropic or myopic children.16
Spending more time outdoors is a simple, effective and achievable intervention which also may have positive effects on other factors of a child’s life such as reduction in body mass index (BMI), and less sedentary behaviours.17 Don’t forget to encourage sun safety as well.
Low-concentration atropine
Four studies to date on low-concentration atropine suggest that it may be useful for delaying the onset of myopia in children at risk.18-21 Overall, varying concentrations of atropine from 0.01% to 0.05% have been shown to reduce the incidence of myopia and result in myopic shifts and axial length growth at around half the rate of the untreated children. Although these studies employed varying concentrations of atropine, the outcomes appear to point to stronger concentrations for younger children. Three of these four studies were conducted on Chinese children, so efficacy for other ethnicities is yet to be determined. From what we know about 0.01% atropine for myopia progression (less effective for Asian children22,23, some efficacy for children in North America24 and European children25), the same could be true for pre-myopia treatment.
Would you prescribe atropine for a child with pre-myopia? Ultimately this comes down to collaborative communication with the parents to gain informed consent. Read more in our article Atropine for pre-myopia.
Myopia control spectacles
Highly aspherical lenslet (HAL) spectacle lenses have been commercially available since 2022 (Essilor® Stellest®) and have established solid efficacy in controlling axial elongation and myopic progression in myopic children.26 In 2024, Zhang et al investigated the use of HAL spectacle lenses to slow axial elongation and myopic refractive shifts in pre-myopic children.27
This was the first study to explore the early intervention and prevention of myopia using an optical treatment. A 1-year randomized controlled trial was performed where 108 Chinese children aged 6 to less than 10 years (mean age 7.0 years) with spherical equivalent refractive error 0.00 to +2.00 D, were randomly assigned either HAL or single vision lens (SVL) spectacles to wear at least 5 days per week and at least 4 hours per day. All lenses were prescribed with 0.00 dioptres. There was a clear relationship between increased wearing time and smaller changes in AL and SERE. Wearing spectacle lenses with HAL for at least 30 hours per week (exceeding the mean wearing time) significantly reduced AL elongation, with 0.11mm growth in one year compared to 0.27mm in SVL wearers.
This data indicates that children with pre-myopia can potentially benefit from wearing HAL spectacles, provided wearing time of at least 30 hours/week is achieved. The 2024 International Myopia Conference (IMC) brought forward 2 more studies which reported axial elongation slowing using plano HAL lenses among pre-myopic children.28,29
Read more about the published study in our article Spectacles with highly aspheric lenslets for pre-myopia and our Q&A Interview The ‘hyperopic reserve’ and treatment in pre-myopia with Chinese ophthalmologist Dr Peter Chen.
Logically, this directs attention towards whether the other next-generation myopia control spectacle lenses are able to replicate similar effects.
DIMS lenses (Defocus Incorporated Multiple Segments) are a close competitor to HAL lenses in terms of myopia control efficacy and design principles. Yang et al at the 2024 IMC reported good adaptability of pre-myopic children to full time wear (≥ 10 hours) of DIMS spectacle lenses. Their efficacy data indicated an increase in SER +0.16D and AL +0.10 mm over 6 months, with no control group.30 Results for other spectacle lens types, such as ‘Multiple defocus’31 and ‘Multizone-defocus-plano’32 lenses have indicated early efficacy in slowing myopic progression and axial elongation in Chinese pre-myopic children, again with wearing time influencing outcomes.
As this area of myopia research grows, this may become a very low risk intervention option for some children. The biggest challenge with prescribing spectacles for a child with presumably normal unaided acuity is managing compliance and gaining traction with parents.
Repeated low-level red light (RLRL) therapy
RLRL therapy has received growing attention within the myopia management sphere in recent years as numerous clinical trials have reported the effectiveness of this treatment in slowing axial elongation and myopia progression in children.33 Among these, one study emerged which explored the use of RLRL treatment for pre-myopes.
He et al34 in 2023 assessed the efficacy and safety of RLRL therapy in preventing incident myopia among pre-myopic children. A 12-month randomized clinical trial was conducted in China on 278 children aged 6 to 11 years with pre-myopia, defined as spherical equivalent refractive error ranging from +0.50 D to -0.50 D. Half of the cohort received two, 3-minute RLRL therapy (Eyerising Myopia Management Device) sessions per day, for five days a week, while the other half were controls. They found reduced myopic shifts of 0.17mm in AL and 0.41D for SER after exposure to repeated low-level red light. For those able to continue therapy uninterrupted (n=9), there was a greater reduction in myopia incidence. The RLRL was well-tolerated by the children with no persistent symptoms or structural changes on OCT. Read more in our article Can red light therapy delay myopia onset?.
These early findings suggest RLRL may be a safe and effective therapy for myopia prevention in pre-myopic children. Despite the convincing efficacy of RLRL therapy in recent studies, further studies need to confirm tolerance and safety over longer periods and with other RLRL devices.
Pre-myopia interventions without direct research evidence (but which may make logical sense)
Treating binocular vision disorders
It would make logical sense that if a child presents with a binocular vision disorder linked to myopia onset, that managing the disorder may reduce risk. These specific disorders are:
- Higher accommodative convergence (AC/A) ratios, typically seen with esophoria, have an increased risk of myopia development within one year of over 20 times.4
- Accommodative lag may also be a risk factor but there is conjecture.5
- Intermittent exotropia (IXT) has also been associated with onset of myopia - 50% of children with IXT are myopic by age 10, and 90% by age 20.6
It's important to note, though, that intervening in the above disorders for the purposes of delaying or preventing myopia onset is not evidence based - no study has been published to this effect. It is worth treating these disorders regardless, especially considering that binocular vision disorders can cause educational delays, asthenopia and headaches in children.35
Plano myopia control contact lenses
There is no evidence (yet) that treating children classified as pre-myopic with myopia control contact lenses are effective in preventing the onset of myopia. Contact lenses, by nature, could be more challenging a prospect for pre-myopia management than spectacles or even atropine. In families who already have another sibling wearing contact lenses, potential strong enthusiasm to utilise an effective treatment is understandable.
When faced with clear progressors (children who have rapidly changed from hyperopic to plano) and strong risk factors in these circumstances of a family keen for treatment, weighing up the risk and benefits of contact lens treatment with the patient and parent should be done clearly and carefully. For more information on paediatric contact lens wear, see our article Contact Lens Safety in Kids.
What to do next for the pre-myope
If the conversation has already occurred with parents on the identification and risks of pre-myopia, and outdoor activity and myopia control options discussed - and a child does progress to myopia, this makes subsequent myopia control intervention an easier decision for both practitioner and family. Where there is opportunity to intervene beforehand to delay myopia onset, though, this is the ideal outcome. Intervention could mean firstly discussing the visual environment and reviewing more frequently; through to prescribing one or more of the evidence-based treatments detailed above.
By identifying pre-myopes as part of your routine clinical paediatric care, you will better integrate myopia management into your practice. Children can progress quickly, especially if you have already identified them as high risk, so ensuring that they are reviewed in at least six-monthly intervals is important.
Meet the Authors:
About Kate Gifford
Dr Kate Gifford is an internationally renowned clinician-scientist optometrist and peer educator, and a Visiting Research Fellow at Queensland University of Technology, Brisbane, Australia. She holds a PhD in contact lens optics in myopia, four professional fellowships, over 100 peer reviewed and professional publications, and has presented more than 200 conference lectures. Kate is the Chair of the Clinical Management Guidelines Committee of the International Myopia Institute. In 2016 Kate co-founded Myopia Profile with Dr Paul Gifford; the world-leading educational platform on childhood myopia management. After 13 years of clinical practice ownership, Kate now works full time on Myopia Profile.
About Cassandra Haines
Cassandra Haines is a clinical optometrist, researcher and writer with a background in policy and advocacy from Adelaide, Australia. She has a keen interest in children's vision and myopia control.
About Brian Peng
Brian is a clinical optometrist based in Sydney, Australia. He graduated with a Master of Clinical Optometry from the University of New South Wales in 2020.
Read Brian's work on our My Kids Vision website, our public awareness platform. Brian also works on development of various new resources across MyopiaProfile.com.
References
- Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, Rahi J, Resnikoff S, Vitale S, Yannuzzi L. IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30.
- Jones LA, Sinnott LT, Mutti DO, Mitchell GL, Moeschberger ML, Zadnik K. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3524-32.
- Rose KA, Morgan IG, Ip J, Kifley A, Huynh S, Smith W, Mitchell P. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology. 2008 Aug;115(8):1279-85.
- Mutti DO, Jones LA, Moeschberger ML, Zadnik K. AC/A ratio, age, and refractive error in children. Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2469-78.
- Mutti DO, Mitchell GL, Hayes JR, Jones LA, Moeschberger ML, Cotter SA, Kleinstein RN, Manny RE, Twelker JD, Zadnik K, the CLEERE Study Group. Accommodative Lag before and after the Onset of Myopia. Invest Ophthalmol Vis Sci. 2006;47:837-846.
- Ekdawi NS, Nusz KJ, Diehl NN, Mohney BG. The development of myopia among children with intermittent exotropia. Am J Ophthalmol. 2010;149(3):503-507.
- Zadnik K, Sinnott LT, Cotter SA, Jones-Jordan LA, Kleinstein RN, Manny RE, Twelker JD, Mutti DO, Collaborative Longitudinal Evaluation of E, Refractive Error Study Group. Prediction of Juvenile-Onset Myopia. JAMA Ophthalmol. 2015;133:683-689.
- Mutti DO, Hayes JR, Mitchell GL, Jones LA, Moeschberger ML, Cotter SA, Kleinstein RN, Manny RE, Twelker JD, Zadnik K. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2007;48:2510-2519.
- Zadnik K, Mutti DO, Mitchell GL, Jones LA, Burr D, Moeschberger ML. Normal eye growth in emmetropic schoolchildren. Optom Vis Sci. 2004 Nov;81(11):819-28.
- Bullimore MA, Brennan NA. Myopia: An ounce of prevention is worth a pound of cure. Ophthalmic Physiol Opt. 2023 Jan;43(1):116-121
- Xiong S, Sankaridurg P, Naduvilath T, Zang J, Zou H, Zhu J, Lv M, He X, Xu X. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017 Sep;95(6):551-566.
- French AN, Ashby RS, Morgan IG, Rose KA. Time outdoors and the prevention of myopia. Exp Eye Res. 2013 Sep;114:58-68.
- Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012 Nov;31(6):622-60.
- Flitcroft DI, Harb EN, Wildsoet CF. The Spatial Frequency Content of Urban and Indoor Environments as a Potential Risk Factor for Myopia Development. Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):42.
- Yi X, Wen L, Gong Y, Zhe Y, Luo Z, Pan W, Li X, Flitcroft DI, Yang Z, Lan W. Outdoor Scene Classrooms to Arrest Myopia: Design and Baseline Characteristics. Optom Vis Sci. 2023 Aug 1;100(8):543-549.
- Lan W, Pan W, Wen L, Luo Z, Flitcroft DI, Yang Z. Effect of Outdoor Scene Classrooms on Myopia Prevention and Control: One-year Result from a Randomized Clinical Trial. Invest Ophthalmol Vis Sci 2024;65(7):129.
- Centis E, Marzocchi R, Di Luzio R, Moscatiello S, Salardi S, Villanova N, Marchesini G; G. C. Croce School of Health Promotion. A controlled, class-based multicomponent intervention to promote healthy lifestyle and to reduce the burden of childhood obesity. Pediatr Obes. 2012 Dec;7(6):436-45.
- Fang PC, Chung MY, Yu HJ, Wu PC. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther. 2010 Aug;26(4):341-5.
- Jethani J. Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes. Indian J Ophthalmol. 2022 Jan;70(1):238-240.
- Wang W, Zhang F, Yu S, Ma N, Huang C, Wang M, Wei L, Zhang J, Fu A. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial. Eur J Pediatr. 2023 Jun;182(6):2597-2606.
- 21. Yam JC, Zhang XJ, Zhang Y, Yip BHK, Tang F, Wong ES, Bui CHT, Kam KW, Ng MPH, Ko ST, Yip WWK, Young AL, Tham CC, Chen LJ, Pang CP. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA. 2023 Feb 14;329(6):472-481.
- Yam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF, Kam KW, Ko ST, Yip BHK, Young AL, Tham CC, Chen LJ, Pang CP. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression Study: Continued Versus Washout: Phase 3 Report. Ophthalmology. 2021 Oct 7:S0161-6420(21)00745-4.
- Lee SS, Lingham G, Blaszkowska M, Sanfilippo PG, Koay A, Franchina M, Chia A, Loughman J, Flitcroft DI, Hammond CJ, Azuara-Blanco A, Crewe JM, Clark A, Mackey DA. Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trial. Clin Exp Ophthalmol. 2022 Dec;50(9):1001-1012.
- Zadnik K, Schulman E, Flitcroft I, Fogt JS, Blumenfeld LC, Fong TM, Lang E, Hemmati HD, Chandler SP; CHAMP Trial Group Investigators. Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial. JAMA Ophthalmol. 2023 Oct 1;141(10):990-999.
- Loughman J, Kobia-Acquah E, Lingham G, Butler J, Loskutova E, Mackey DA, Lee SSY, Flitcroft DI. Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population. Acta Ophthalmol. 2024 May;102(3):e245-e256.
- Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Spiegel DP, Drobe B, Chen H. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 2022 May 1;140(5):472-478.
- Zhang Z, Zeng L, Gu D, Wang B, Kang P, Watt K, Zhou J, Zhou X, Chen Z, Yang D, Chen C, Wang X, Zhou X, Chen Z. Spectacle Lenses With Highly Aspherical Lenslets for Slowing Axial Elongation and Refractive Change in Low-Hyperopic Chinese Children: A Randomized Controlled Trial. Am J Ophthalmol. 2024 Aug 27;269:60-68.
- Sun A, Li X, Zhu P, Xie F, Wu Y. The efficacy of plano lenses with highly aspherical lenslets in children with pre-myopia. Paper presented at: International Myopia Conference; 2024 September 25-28; Hainan, China.
- Woo O. Myopia control effect of spectacles lenses with highly aspherical lenslets on axial elongation among pre-myopic children in Sydney. Paper presented at: International Myopia Conference; 2024 September 25-28; Hainan, China.
- Yang HY, Tsai DC, Yang YC, Wang CY. Preliminary results and adaptability to the defocus incorporated multiple segments spectacles lenses among pre-myopic children of preschool age. Paper presented at: International Myopia Conference; 2024 September 25-28; Hainan, China.
- Rao J, Tang Y. The efficacy of multiple defocus spectacle lenses in slowing pre-myopia progression: a retrospective real-world study. Paper presented at: International Myopia Conference; 2024 September 25-28; Hainan, China.
- Ran G, Li X, Yang Z. The effectiveness of multizone-defocus-plano (MDP) prevent myopia. Paper presented at: International Myopia Conference; 2024 September 25-28; Hainan, China.
- Tang J, Liao Y, Yan N, Dereje SB, Wang J, Luo Y, Wang Y, Zhou W, Wang X, Wang W. Efficacy of Repeated Low-Level Red-Light Therapy for Slowing the Progression of Childhood Myopia: A Systematic Review and Meta-analysis. Am J Ophthalmol. 2023 Aug;252:153-163.
- He X, Wang J, Zhu Z, Xiang K, Zhang X, Zhang B, Chen J, Yang J, Du L, Niu C, Leng M, Huang J, Liu K, Zou H, He M, Xu X. Effect of Repeated Low-level Red Light on Myopia Prevention Among Children in China With Premyopia: A Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e239612.
- American Optometric Association. Care of the Patient with Accommodative and Vergence Dysfunction (St Louis, 2001). Accessed 19 October 2020.
Enormous thanks to our visionary sponsors
Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.